Morgan Stanley Overweight Edwards Lifesciences, Potential Product Markets Are Enormous

By: via Benzinga
In a report published Monday, Morgan Stanley analyst David R. Lewis upgraded the rating on Edwards Lifesciences Corp (NYSE: EW) from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.